Matsumoto, T., Yamamoto, Y., Kuriona, Y., Okazaki, U., Kimura, S., Miura, K., . . . Takatani, M. (2020). Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses. BMC Cancer, 20(1), 1. https://doi.org/10.1186/s12885-020-07176-7
Chicago Style (17th ed.) CitationMatsumoto, Toshihiko, et al. "Efficacy and Safety of Nivolumab for Advanced Gastric Cancer Patients with Poor Performance Statuses." BMC Cancer 20, no. 1 (2020): 1. https://doi.org/10.1186/s12885-020-07176-7.
MLA (9th ed.) CitationMatsumoto, Toshihiko, et al. "Efficacy and Safety of Nivolumab for Advanced Gastric Cancer Patients with Poor Performance Statuses." BMC Cancer, vol. 20, no. 1, 2020, p. 1, https://doi.org/10.1186/s12885-020-07176-7.